Growth Commitment Results Impact Partners 2013 DATA BOOK DuPont Investor Relations Contents 1 DuPont Overview 2 Corporate Financial Data Consolidated Income Statements Carl Lukach Tim Johnson Randy Stone Consolidated Balance Sheets Vice President Director Director (302) 774-0001 (515) 535-2177 (302) 774-9810 Consolidated Statements of Cash Flows Selected Additional Data 6 DuPont Science & Technology 8 Business Segments Agriculture Electronics & Communications Industrial Biosciences Amy Trojanowski Patricia Esham Director Specialist Nutrition & Health (302) 774-2297 (302) 774-9870 Performance Materials Safety & Protection Performance Chemicals The DuPont DATA BOOK has been prepared to assist financial analysts, portfolio managers and others in understanding and evaluating the company. This book presents graphics, tabular and other 22 Corporate Financial Data statistical data about the consolidated company and its business segments. Segment Information Forward-Looking Statements This DATA BOOK contains forward-looking statements which may be identified by their use of Selected Additional Data words like “plans,” “expects,” “will,” “anticipates,” “believes,” “intends,” “estimates” or other words of similar meaning. Although they reflect our current expectations, these statements are not Inside Back Cover guarantees of future performance, but involve a number of risks, uncertainties, and assumptions. Some of which include: fluctuations in energy and raw material prices; failure to develop and market Board of Directors and new products and optimally manage product life cycles; global economic and capital markets conditions; litigation and environmental matters; changes in laws and regulations or political DuPont Leadership conditions; business or supply disruptions; ability to protect and enforce the company’s intellectual property rights; successful integration of acquired business and separation of underperforming Individual Shareholder Relations: or non-strategic assets; and successful completion of the proposed spinoff of the Performance Chemicals segment including ability to fully realize the expected benefits of the proposed spinoff. (302) 774-3033 The company does not undertake to update any forward-looking statements as a result of future developments or new information. Main Office Number: Use of Non-GAAP Measures (302) 774-4994 As a supplement to DuPont financial results prepared in accordance with U.S. generally accepted accounting principles (GAAP), this DATA BOOK presents non-GAAP measures. Consolidated Internet: www.dupont.com company and segment results are shown on an operating earnings basis, which excludes significant items and non-operating pension and other postretirement employee benefit costs. Non-GAAP measures include but are not limited to operating earnings and operating earnings per share; operating earnings before interest, taxes, and noncontrolling interests (EBIT), as defined by the company; operating earnings before interest, taxes, noncontrolling interests, depreciation and amortization (EBITDA); and free cash flow. Non-GAAP measures are not a substitute for GAAP results. The company uses non-GAAP measures to evaluate and manage the company’s operations. The company believes that a discussion of operating results provides a useful analysis of ongoing operations. The determination of significant items may not be comparable to similarly titled measures used by other companies. This data should be read in conjunction with previously published company reports on Forms 10-K, 10-Q, and 8-K. These reports, along with reconciliations on non-GAAP measures to GAAP are available on the Investor Center of www.dupont.com. For complete details of significant items, see DuPont quarterly earnings news releases. The DuPont DATA BOOK is available at www.dupont.com. April 2014 DuPont Overview 2013 Highlights Strategic moves like the purchase of Danisco, the sale of In 2013, DuPont delivered strong results, as we continued to generate Performance Coatings and the announced intent to separate our solid returns for our shareholders. Our strategy is working. In the Performance Chemicals segment have helped to strengthen and past five years, we have delivered a total shareholder return of sharpen our portfolio, as we move to a higher-growth, less cyclical 214 percent;1 nearly double that of the S&P 500. 2013 was a year DuPont. Further, the planned spin-off of the Performance Chemicals of progress. In February, we sold our Performance Coatings segment results in two strong public companies, each with its own business and in October, we announced our intent to separate the purpose and strategic priorities. DuPont will continue as a higher- Performance Chemicals segment through a spin-off to shareholders. growth science company, delivering shareholder value through These portfolio changes, along with our 2011 Danisco acquisition are earnings and revenue growth, and Performance Chemicals will reshaping DuPont as a higher-value, higher-growth science company. provide value to shareholders as a strong, cash-generating company. The power of our science and R&D, Freeing Cash, Growing Dividends our solid customer relationships, SHAREHOLDER Our productivity efforts over the last five years have freed significant and our emphasis on disciplined cash and dividends remain a priority. We have had 438 consecutive RETURN execution enabled us to grow both quarters of dividend payouts and we recently restarted dividend DELIVERED IN THE revenue and operating earnings increases. In 2013, we repurchased $1 billion of our common stock, per share2 by 3 percent last year, PAST FIVE YEARS and in January 2014, announced a new $5 billion share repurchase overcoming the operating earnings program, of which we expect to complete $2 billion this year. decline in Performance Chemicals, an uneven global economy, and soft industrial demand. Beyond the decline in Performance Chemicals, our businesses grew their segment pretax operating Building a World-Class Team earnings2 by 11 percent. After reinvesting $2.2 billion in research and It is the talent, determination and dedication of our people that have development and $1.9 billion in capital expenditures, we generated made DuPont successful. Our leaders remain focused on our purpose $1.3 billion of free cash flow3 and returned $2.7 billion to shareholders as a science company. Our world-class scientists keep our pipeline through dividends and share repurchases. filled with sustainable, innovative and marketable products. And each of our 64,000 employees contributes to making lives better, safer and Focused on Growth healthier for people everywhere. Our focus on execution and capital allocation allows us to concentrate our resources on growth opportunities that enhance Priorities for 2014 and Beyond shareholder value. Operationally, we continue to emphasize: Looking ahead to 2014, we are encouraged by global macro trends and the significant momentum generated over the past five years. • Innovation: Our R&D is focused on businesses that have a record DuPont will continue to deliver greater value for shareholders through of generating faster growth and higher cash returns. an intense focus on our strategic priorities: • Global Reach: We leverage our presence in more than 90 • Agriculture & Nutrition: Extend our leadership position across the countries to drive penetration in fast-growing developing markets. high-value, science-driven segments of the agriculture-to-food • Execution: We deliver ongoing productivity gains that allow us to value chains. shift resources to higher-growth businesses and improve return • Industrial Biosciences: Build transformational new businesses, on capital, while continuing to return cash to shareholders. based on our world-leading biotechnology capabilities. Market-Driven Science • Advanced Materials: Strengthen and grow our leading position in differentiated, high-value materials businesses by leveraging new Science is at the heart of DuPont and our higher-value, higher-growth technologies. strategy. Throughout our 211-year history, we have always drawn on our scientific expertise to create innovative solutions for customers. We will continue to refine and enhance our portfolio around these From gunpowder to nylon, to DuPont™ Kevlar® aramid fibers, to DuPont™ priorities guided by a determination that our science can give us a Rynaxypyr® insect control, science-based solutions have driven growth competitive edge. and given us a competitive advantage in the marketplace. With a 211-year history fueling our confidence, we remain steadfast in Today, our core technologies – biology, chemistry, materials science our conviction that science-powered innovation will provide answers and engineering – uniquely position us to address the needs of large, to some of the world’s most complex problems, deliver solutions for profitable secular growth markets. And our science is helping to solve customers and provide the superior returns shareholders expect. global problems such as providing safer and more nutritious food, reducing our dependence on fossil fuels and protecting people and 1 Datastream as of 12/31/2013, Bloomberg, Capital IQ, FactSet. DuPont and S&P 500 Index are USD market cap-weighted, and assume dividends are reinvested at the closing price the environment. applicable on the ex-dividend date. 2 See reconciliations of Non-GAAP measures to GAAP throughout this document. Targeted Investment in Higher Growth Areas 3 Free cash flow represents 2013 cash provided by operating